经尿道前列腺等离子双极汽化电切术治疗高危前列腺增生症

Transurethral plasmakentic vaporization of prostate for treatment of high-risk benign prostatic hyperplasia

目的探讨经尿道前列腺等离子双极汽化电切术治疗高危前列腺增生症的安全性和有效性。方法回顾性分析经尿道前列腺等离子双极汽化电切术治疗高危前列腺增生症76例的临床资料。结果本组76例高危前列腺增生症患者安全度过围手术期,手术时间40-120min,平均（65±15.5）min;切除前列腺组织30-75 g,平均（40.55±5.4）g;国际前列腺症状评分（IPSS）、生活质量评分（QOL）、最大尿流率（Qmax）、残余尿（RUV）与术前相比有明显改善,差异有统计学意义（P〈0.05）。结论经尿道等离子双极汽化电切术是治疗高危前列腺增生症的安全有效的方法。

Objective To investigate the safety and efficacy of transurethral plasmakentie vaporization of prostate（TUPKVP） for treatment of high-risk benign prostatic hyperplasia（BPH）. Methods The clinical data of 76 patients with high-risk BPH treated with TUPKVP were reviewed. Results All patients were safe during the perioperative period. The mean operative time was （65 ± 15.5）min （ranged from 40min to 120min）. The resected BPH tissue weighted （40.55 ± 5.4）g （ranged from 30g to 75g）. IPSS,QOL, Qmax and RUV improved significantly compared with pre-operation（ P 〈 0.05）. Conclusion TUPKVP is an effective and safe therapy for high-risk BPH.